Skip to main content
. 2012 Feb 22;7(2):e31522. doi: 10.1371/journal.pone.0031522

Figure 4. L-DOPA alleviated age-related motor deficits in Aldh1a1−/−×Aldh2−/− mice.

Figure 4

Performance on the accelerating rotarod was measured in Aldh1a1 −/−×Aldh2 −/− double knockout mice and age-matched wild type controls (A) before and (B) after L-DOPA treatment. Stride length was measured in Aldh1a1 −/−×Aldh2 −/− double knockout mice and age-matched wild type controls (C) before and (D) after L-DOPA treatment. Measurement of stride length after elimination of L-DOPA (E) was performed 7 days after L-DOPA injection. Data in all panels are expressed as mean ± SEM of the following number of animals in each age group: young (wt = 5, ko = 6), middle-aged (wt = 5, ko = 13) and old (wt = 13, ko = 16) male mice. Asterisks above bars indicate significant difference between age-matched wt and ko groups. Asterisks above lines indicate significant difference between indicated means. *P<0.05; **P<0.01; ***P<0.001.